Dimethyl Fumarate Capsule, Delayed Release
Product Images NDC 24979-128

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dimethyl Fumarate (NDC 24979-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (D120)

This is a description of a medication named Dimethyl Fumarate. It is in the form of delayed-release capsules which are to be swallowed whole. Each capsule has 120mg of Dimethyl Fumarate. It is recommended to be taken orally twice a day. The medication should be stored in its original container and protected from light, as well as kept at a temperature of 20-25°C (68-77°F). The product was manufactured by TWi Pharmaceuticals in Taiwan and is distributed by TWi Pharmaceuticals USA in Paramus, New Jersey. The capsules contain color additives, including FDC Yellow No.5.*

FDA Label Image

Image Description (D240)

This is a medication called Dimethyl Fumarate, available in delayed-release capsules of 240 mg for oral administration. It is prescribed to be taken twice a day by swallowing the capsule whole. The medication should be stored in its original container, protected from light at a temperature of 20°C to 25°C (68°F to 77°F). The capsules contain color additives including FDC Yellow No. 5 (tartrazine). The manufacturer is TWi Pharmaceuticals, with the address in the USA and the manufacturing plant located in Taoyuan City, Taiwan.*

FDA Label Image

Image Description (Dtfclinical)

This is a table displaying the percentage of subjects with confirmed progression of disability over time, with a specific definition provided. The data is related to a study comparing the effects of a medication (ethyl fumarate delayed-release capsules 240mg BID) with a placebo. The study involved 409 subjects receiving the medication and 408 receiving the placebo.*

FDA Label Image

Logo (Logo)

FDA Label Image

Tec00-0006-01 (Tec00 0006 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.